ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,127.79
1.26%
Dow Jones
38,675.68
1.18%
US Dollar vs MXN
16.9724
0.00%
Brent Oil
82.765
0.00%
Bitcoin
63,765.99
1.39%
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. First Wave BioPharma Inc (FWBI)

  7. First Wave BioPharma Inc (FWBI) Noticias

FWBI First Wave BioPharma Inc

2.60
-0.19 (-6.81%)
03 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
First Wave BioPharma Inc FWBI NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
-0.19 -6.81% 2.60 23:00:03
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
2.78 2.59 2.9872 2.60 2.79
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
24/4/202406:00GLOBEFirst Wave BioPharma Announces Invited Paper for Special..
17/4/202406:00GLOBEFirst Wave BioPharma CEO James Sapirstein to Present at the..
15/4/202406:00GLOBEFirst Wave BioPharma CEO James Sapirstein to Participate in..
18/3/202406:00GLOBEFirst Wave BioPharma Announces Two Abstracts on Celiac..
14/3/202405:00GLOBEFirst Wave BioPharma Announces Completion of Business..
05/3/202416:26EDGAR2Form 8-K - Current report
05/3/202406:00GLOBEFirst Wave BioPharma to Participate In ‘Fireside Chat’ at..
04/3/202416:29EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
04/3/202407:00GLOBEFirst Wave BioPharma, Inc. to Raise Approximately $4.0..
13/2/202406:00GLOBEFirst Wave BioPharma CEO to Present at the BIO CEO &..
23/1/202406:00GLOBEFirst Wave BioPharma to Present at the DealFlow MicroCap..
18/1/202415:01EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
17/1/202423:15EDGAR2Form EFFECT - Notice of Effectiveness
17/1/202415:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202406:00GLOBEFirst Wave BioPharma CEO to Present at the Sequire Investor..
08/1/202416:14EDGAR2Form S-3 - Registration statement under Securities Act of..
04/1/202416:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202416:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202407:22EDGAR2Form 8-K - Current report
04/1/202405:00GLOBEFirst Wave BioPharma Chairman and CEO Issues Letter to..
03/1/202418:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/12/202311:21EDGAR2Form RW - Registration Withdrawal Request
27/12/202316:23EDGAR2Form 8-K - Current report
27/12/202310:55GLOBEFirst Wave BioPharma Announces Exercise of Warrants and..
27/12/202307:04EDGAR2Form S-1/A - General form for registration of securities..
27/12/202305:15EDGAR2Form 8-K - Current report
27/12/202305:00GLOBEFirst Wave BioPharma Announces Streamlining of Clinical..
18/12/202306:00EDGAR2Form 8-K - Current report
18/12/202305:00GLOBEFirst Wave BioPharma Announces Entry into Term Sheet for..
15/12/202320:48EDGAR2Form S-1/A - General form for registration of securities..
14/12/202308:15EDGAR2Form 8-K - Current report
14/12/202308:15GLOBEFirst Wave BioPharma Announces 1-for-20 Reverse Stock Split..
06/12/202306:00GLOBEFirst Wave BioPharma to Participate in BIO Partnering @JPM..
05/12/202306:00GLOBEFirst Wave BioPharma CEO James Sapirstein to Moderate Panel..
13/11/202315:20EDGAR2Form DEF 14A - Other definitive proxy statements
13/11/202315:16EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/11/202315:51EDGAR2Form S-1 - General form for registration of securities under..
31/10/202316:24EDGAR2Form PRER14A - Preliminary Proxy Soliciting materials
31/10/202316:21EDGAR2Form 8-K - Current report
12/10/202316:06EDGAR2Form PRE 14A - Other preliminary proxy statements
10/10/202315:06EDGAR2Form 8-K/A - Current report: [Amend]
10/10/202306:00GLOBEDate and Time Announced for First Wave BioPharma CEO James..
06/10/202315:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/10/202306:00GLOBEFirst Wave BioPharma CEO James Sapirstein to Present at the..
02/10/202308:20EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
22/9/202308:38EDGAR2Form S-3 - Registration statement under Securities Act of..
15/9/202315:05EDGAR2Form 8-K - Current report
15/9/202307:45GLOBEFirst Wave BioPharma To Present at the BIO Investor Forum
14/9/202309:43GLOBEFirst Wave BioPharma Announces Exercise of Warrants and..
14/9/202305:19EDGAR2Form 8-K - Current report

Su Consulta Reciente

NASDAQ
FWBI
First Wave BioPharma
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados